Tuesday, Dec 19, 2023 · SEC filings
What the smart money revealed on Dec 19
989 insider filings came in. We hid 94 planned (10b5-1) sellers and 659 people whose filings were routine, like grants and tax withholding.
3 insiders at Perspective Therapeutics (CATX) bought $228K of stock
Roles: CFO, Chief Medical Officer, Director. Several insiders buying in the same few days is rare.
Beyond Air (XAIR) Director Robert Carey bought $1.97M
1.2M shares on the open market. Not a grant or an option exercise.
Calamos Long/Short Equity & Dynamic Income Trust (CPZ) President and Chairman John Calamos Sr. bought $497K
33,695 shares on the open market. Not a grant or an option exercise.
Texas Community Bancshares (TCBS) Director Anthony Scavuzzo bought $428K
33,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.
B. Riley Financial (RILY) Co-CEO Thomas Kelleher bought $404K
20,000 shares on the open market. Not a grant or an option exercise.
AerSale (ASLE) Director Michael Kirton sold $50M
Not marked as a planned 10b5-1 sale. Sold 29% of the shares they held directly. Still holds 9.57M shares.
Arcellx (ACLX) Chief Medical Officer Christopher Heery sold $6.02M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 7,795 shares directly.
Pioneer Natural Resources (PXD) Director Maria Dreyfus sold $2.41M
Not marked as a planned 10b5-1 sale. Sold 72% of the shares they held directly. Still holds 4,066 shares.
Show 45 more real buys
Show 150 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Dec 13–19
Open-market buys by officers and directors, filed in the 7 days up to Dec 19.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.